Consensus recommendations in the management of jaw (gnathic) osteosarcoma
Open Access
Abstract
Gnathic osteosarcoma (OS), which includes mandibular and maxillary jaw OSs, account for 6%–9% of OS. Single‐institutional and multi‐institutional retrospective studies, as well as population‐level databases, suggest that clinical differences exist among gnathic OS and OS of other sides, including other craniofacial OS. To date, no specific prospective studies of gnathic OS have been reported, and aspects of clinical management are controversial. Some elements of care are aligned with extragnathic OS, e.g., margin negative (R0) surgery, whereas others, such as chemotherapy and radiation, are not clearly defined. The authors reviewed the available literature for the diagnosis, treatment, and supportive/survivorship care patients with gnathic OS and offer consensus statements for the comprehensive management of this rare disease.Keywords
This publication has 74 references indexed in Scilit:
- Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young AdultsAmerican Journal of Roentgenology, 2001
- FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosisCancer, 1999
- Osteosarcoma of the head and neck: A review of the johns hopkins experienceThe Laryngoscope, 1999
- Osteosarcoma of the jaw bonesInternational Journal of Oral and Maxillofacial Surgery, 1997
- Osteosarcoma of the Head and Neck: Meta‐analysis of Nonrandomized StudiesThe Laryngoscope, 1997
- Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients.Journal of Clinical Oncology, 1997
- The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*Journal of Bone and Joint Surgery, 1996
- The istituto rizzoli-beretta experience with osteosarcoma of the jawCancer, 1991
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986